MC
CELG

Middleton & Co’s Celgene Corp CELG Stock Holding History

Middleton & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,743
Closed -$254K – 169
2017
Q3 		$254K Hold
1,743
– – 0.05% 155
2017
Q2 		$226K Sell
1,743
-58
-3% -$7.11K 0.05% 143
2017
Q1 		$224K Hold
1,801
– – 0.05% 149
2016
Q4 		$208K Buy
+1,801
New +$201K 0.05% 151
2016
Q1 		– Sell
-1,801
Closed -$216K – 161
2015
Q4 		$216K Buy
+1,801
New +$208K 0.05% 154
2015
Q3 		– Sell
-1,801
Closed -$208K – 158
2015
Q2 		$208K Sell
1,801
-50
-3% -$5.72K 0.05% 151
2015
Q1 		$213K Hold
1,851
– – 0.05% 152
2014
Q4 		$207K Buy
+1,851
New +$195K 0.05% 152

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Middleton & Co's CELG Position: Q4 2017 in Review

Middleton & Co sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,743 shares — an estimated $254K sold.

Middleton & Co first reported a position in CELG in Q4 2014 and held it in 8 quarters. The position peaked at $254K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Middleton & Co reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Middleton & Co sold 1,743 Celgene Corp shares in Q4 2017, an estimated $254K.
  • Middleton & Co first reported a position in Celgene Corp in Q4 2014 and held it in 8 quarters.
  • Middleton & Co's Celgene Corp position peaked at $254K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Middleton & Co's 13F filing for Q4 2017, filed 25 Jan 2018.